Skip to main content

Advertisement

SpringerLink
Log in

Immunizations and risk of multiple sclerosis: systematic review and meta-analysis

  • Review
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The role of vaccinations in risk of developing multiple sclerosis (MS) or in risk of relapse has not been well established. The aim of this study was to estimate the effect of immunizations on risk of developing MS in adults as well as in subsequent risk of relapse. Systematic search for publications in MEDLINE (1966–January 2011), EMBASE (1977–January 2011) and the Cochrane Central Register of Controlled Trials (CENTRAL) (1961–January 2011). Both randomized clinical trials and non-randomized studies addressing the effect of any Center for Diseases Control (CDC) recommended vaccine for children, adults or travelers and BCG on risk of MS or disease relapse were included. Two reviewers independently extracted information from articles selected using a predefined datasheet. No significant change in the risk of developing MS after vaccination was found for BCG (OR 0.96, 95% CI 0.69–1.34), Hepatitis B (OR 1.00, 95% CI 0.74–1.37), Influenza (OR 0.97, 95% CI 0.77–1.23), Measles–Mumps–Rubella (MMR) (OR 1.02, 95% CI 0.64–1.61), Polio (OR 0.87, 95% CI 0.61–1.25) and Typhoid fever (OR 1.05, 95% CI 0.72–1.53). We found decreased risk of developing MS for Diphtheria (OR 0.60, 95% CI 0.40–0.90) and Tetanus (OR 0.68, 95% CI 0.54–0.84). Influenza immunization was also associated with no change in risk of MS relapse (RR 1.24, 95% CI 0.89–1.72). Risk of developing multiple sclerosis remained unchanged after BCG, Hepatitis B, Influenza, MMR, Polio and Typhoid fever immunization, whereas diphtheria and tetanus vaccination may be associated with a decreased risk of MS. Further research is needed for the remaining vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. WHO (2005) Immunization against diseases of public health importance. World Health Organization (WHO). http://www.who.int/mediacentre/factsheets/fs288/en/index.html. Accessed 25 Aug 2010

  2. Doja A, Roberts W (2006) Immunizations and autism: a review of the literature. Can J Neurol Sci 33(4):341–346

    PubMed  Google Scholar 

  3. Chen RT, Pless R, Destefano F (2001) Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16(3):309–318. doi:10.1006/jaut.2000.0491

    Article  PubMed  CAS  Google Scholar 

  4. Geier DA, Geier MR (2005) A case–control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38(4):295–301

    Article  PubMed  CAS  Google Scholar 

  5. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700

    Article  PubMed  Google Scholar 

  6. CDC (2010) Immunization schedule. Center for Disease Control and Prevention of the United States of America. http://www.cdc.gov/vaccines/recs/schedules/default.htm. Accessed 22 Aug 2010

  7. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557

    Article  PubMed  Google Scholar 

  8. Takkouche B, Cadarso-Suarez C, Spiegelman D (1999) Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 150(2):206–215

    PubMed  CAS  Google Scholar 

  9. Andersen E, Isager H, Hyllested K (1981) Risk factors in multiple sclerosis: tuberculin reactivity, age at measles infection, tonsillectomy and appendectomy. Acta Neurol Scand 63(2):131–135

    Article  PubMed  CAS  Google Scholar 

  10. Bansil S, Singhal BS, Ahuja GK, Riise T, Ladiwala U, Behari M, Cook SD (1997) Multiple sclerosis in India: a case–control study of environmental exposures. Acta Neurol Scand 95(2):90–95

    Article  PubMed  CAS  Google Scholar 

  11. Berr C, Puel J, Clanet M, Ruidavets JB, Mas JL, Alperovitch A (1989) Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France. Acta Neurol Scand 80(1):46–50

    Article  PubMed  CAS  Google Scholar 

  12. Casetta I, Granieri E, Malagù S, Tola MR, Paolino E, Caniatti LM, Govoni V, Monetti VC, Fainardi E (1994) Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 13(3):120–128

    Article  PubMed  CAS  Google Scholar 

  13. Pekmezovic T, Jarebinski M, Drulovic J (2004) Childhood infections as risk factors for multiple sclerosis: Belgrade case–control study. Neuroepidemiology 23(6):285–288. doi:10.1159/000080094

    Article  PubMed  Google Scholar 

  14. Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G (2003) Risk factors of multiple sclerosis: a case–control study. Neurol Sci 24(4):242–247. doi:10.1007/s10072-003-0147-6

    Article  PubMed  CAS  Google Scholar 

  15. Kurtzke JF, Hyllested K, Arbuckle JD, Brønnum-Hansen H, Wallin MT, Heltberg A, Jacobsen H, Olsen A, Eriksen LS (1997) Multiple sclerosis in the Faroe Islands 7 Results of a case control questionnaire with multiple controls. Acta Neurol Scand 96(3):149–157

    Article  PubMed  CAS  Google Scholar 

  16. DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT, Vaccine Safety Datalink Research Group NIP, Centers for Disease Control, Prevention (2003) Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 60(4):504–509. doi:10.1001/archneur.60.4.504

    Article  PubMed  Google Scholar 

  17. Ascherio A, Zhang SM, Hernán MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344(5):327–332

    Article  PubMed  CAS  Google Scholar 

  18. Hernán MA, Jick SS, Olek MJ, Jick H (2004) Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 63(5):838–842

    PubMed  Google Scholar 

  19. Hocine MN, Farrington CP, Touzé E, Whitaker HJ, Fourrier A, Moreau T, Tubert-Bitter P (2007) Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method. Vaccine 25(31):5938–5943. doi:10.1016/j.vaccine.2007.05.032

    Article  PubMed  CAS  Google Scholar 

  20. Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G, Ebers GC, Sadovnick AD, Group CCS (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology 32(4):257–262. doi:10.1159/000201564

    Article  PubMed  Google Scholar 

  21. Touzé E, Fourrier A, Rue-Fenouche C, Rondé-Oustau V, Jeantaud I, Bégaud B, Alpérovitch A (2002) Hepatitis B vaccination and first central nervous system demyelinating event: a case–control study. Neuroepidemiology 21(4):180–186

    Article  PubMed  Google Scholar 

  22. Zipp F, Weil JG, Einhäupl KM (1999) No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 5(9):964–965. doi:10.1038/12376

    Article  PubMed  CAS  Google Scholar 

  23. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S, ViMSS Group (2001) Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. N Engl J Med 344(5):319–326

    Article  PubMed  CAS  Google Scholar 

  24. Bamford CR, Sibley WA, Laguna JF (1978) Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol 35(4):242–243

    PubMed  CAS  Google Scholar 

  25. Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, Doscher CA, Lublin FD, Knobler RL, Trantas F, Kelley L, Smith CR, La Rocca N, Lopez S (1997) A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 48(2):312–314

    PubMed  CAS  Google Scholar 

  26. Mokhtarian F, Shirazian D, Morgante L, Miller A, Grob D, Lichstein E (1997) Influenza virus vaccination of patients with multiple sclerosis. Multiple Scler 3(4):243–247

    Article  CAS  Google Scholar 

  27. Myers LW, Ellison GW, Lucia M, Novom S (1976) Swine-influenza vaccination in multiple sclerosis. N Engl J Med 295(21):1204

    PubMed  CAS  Google Scholar 

  28. Ahlgren C, Torén K, Odén A, Andersen O (2009) A population-based case–control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol 24(9):541–552. doi:10.1007/s10654-009-9367-2

    Article  PubMed  Google Scholar 

  29. Zilber N, Kahana E (1996) Risk factors for multiple sclerosis: a case–control study in Israel. Acta Neurol Scand 94(6):395–403

    Article  PubMed  CAS  Google Scholar 

  30. Compston DA, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA (1986) Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 109(Pt 2):325–344

    Article  PubMed  Google Scholar 

  31. Alter M, Speer J (1968) Clinical evaluation of possible etiologic factors in multiple sclerosis. Neurology 18(2):109–116

    PubMed  CAS  Google Scholar 

  32. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer TT-T, Varonen H, Vist GE, Williams JW, Zaza S, Group GW (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490. doi:10.1136/bmj.328.7454.1490

  33. Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65(3):239–248. doi:10.1002/ana.21640

    Article  PubMed  CAS  Google Scholar 

  34. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7):727–739. doi:10.1016/S1474-4422(10)70094-6

    Article  PubMed  Google Scholar 

  35. Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I, Miller NA, Zhang L, Farmer AD, Bell CJ, Kim RW, May GD, Woodward JE, Caillier SJ, McElroy JP, Gomez R, Pando MJ, Clendenen LE, Ganusova EE, Schilkey FD, Ramaraj T, Khan OA, Huntley JJ, Luo S, Kwok P-Y, Wu TD, Schroth GP, Oksenberg JR, Hauser SL, Kingsmore SF (2010) Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464(7293):1351–1356. doi:10.1038/nature08990

    Article  PubMed  CAS  Google Scholar 

  36. Hernán MA, Olek MJ, Ascherio A (1999) Geographic variation of MS incidence in two prospective studies of US women. Neurology 53(8):1711–1718

    PubMed  Google Scholar 

  37. Munger KL, Zhang SM, O’Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62(1):60–65

    PubMed  CAS  Google Scholar 

  38. Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H (2005) Cigarette smoking and the progression of multiple sclerosis. Brain 128(Pt 6):1461–1465. doi:10.1093/brain/awh471

    Article  PubMed  Google Scholar 

  39. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I. The role of infection. Ann Neurol 61(4):288–299. doi:10.1002/ana.21117

    Article  PubMed  Google Scholar 

  40. Correale J, Fiol M, Gilmore W (2006) The risk of relapses in multiple sclerosis during systemic infections. Neurology 67(4):652–659. doi:10.1212/01.wnl.0000233834.09743.3b

    Article  PubMed  CAS  Google Scholar 

  41. Buljevac D, Flach HZ, Hop WCJ, Hijdra D, Laman JD, Savelkoul HFJ, van Der Meché FGA, van Doorn PA, Hintzen RQ (2002) Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 125(Pt 5):952–960

    Article  PubMed  CAS  Google Scholar 

  42. Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61(2):97–108. doi:10.1002/ana.21067

    Article  PubMed  CAS  Google Scholar 

  43. Hernán MA, Alonso A, Hernández-Díaz S (2006) Tetanus vaccination and risk of multiple sclerosis: a systematic review. Neurology 67(2):212–215. doi:10.1212/01.wnl.0000225079.51201.f9

    Article  PubMed  Google Scholar 

  44. Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300

    PubMed  CAS  Google Scholar 

  45. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 4(10):e297

    Article  PubMed  Google Scholar 

  46. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327(4):248–254. doi:10.1056/NEJM199207233270406

    Article  PubMed  CAS  Google Scholar 

  47. Cabrera-Gómez JA, Echazabal-Santana N, García-González L, Ramos-Cedeño AM, Rodríguez-Roque MO, López-Hernández O, Cabrera-Núñez JA, De González La Nuez J, Téllez L (2002) A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination? Rev Neurol 34(4):358–363

    PubMed  Google Scholar 

  48. Chaves M, Riccio P, Patrucco L, Rojas J, Cristiano E (2009) Longitudinal myelitis associated with yellow fever vaccination. J Neurovirol 15(4):348–350. doi:10.1080/13550280903062805

    Google Scholar 

  49. Miller H, Cendrowski W, Shapira K (1967) Multiple sclerosis and vaccination. Br Med J 2(5546):210–213

    Article  PubMed  CAS  Google Scholar 

  50. Sutton I, Lahoria R, Tan I, Clouston P, Barnett M (2009) CNS demyelination and quadrivalent HPV vaccination. Multiple Scler 15(1):116–119. doi:10.1177/1352458508096868

    Article  CAS  Google Scholar 

  51. Terney D, Beniczky S, Barsi P, Kondákor I, Perényi J, Faludi B, Szapper M, Vécsei L (2006) Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Chin Med J 119(1):77–79

    PubMed  Google Scholar 

  52. Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C (2009) Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology 72(24):2132–2133. doi:10.1212/WNL.0b013e3181aa53bb

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by funding from the Raúl Carrea Institute for Neurological Research, FLENI.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Neurology, Dr Raúl Carrea Institute for Neurological Research, FLENI, Montañeses 2325, 1428, Buenos Aires, Argentina

    Mauricio F. Farez & Jorge Correale

Authors
  1. Mauricio F. Farez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Correale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge Correale.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 338 kb)

Supplementary material 2 (PDF 476 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farez, M.F., Correale, J. Immunizations and risk of multiple sclerosis: systematic review and meta-analysis. J Neurol 258, 1197–1206 (2011). https://doi.org/10.1007/s00415-011-5984-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-5984-2

Keywords

Search

Navigation